Please enable JavaScript to continue using this application.

Compare $ARTV vs $EBS | Chartloom

Compare

$ARTV vs $EBS

Artiva Biotherapeutics Inc · Emergent BioSolutions Inc

ARTV

Artiva Biotherapeutics Inc

EBS

Emergent BioSolutions Inc

Compare $ARTV vs $EBS

Comparing Artiva Biotherapeutics Inc and Emergent BioSolutions Inc

ARTVArtiva Biotherapeutics Inc

EBSEmergent BioSolutions Inc

ARTVArtiva Biotherapeutics Inc

Market cap

$337M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

64.1%

52W performance

131.3%

FCF yield

-22.8%

EBSEmergent BioSolutions Inc

Market cap

$364M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-9.6%

YTD performance

-43.6%

52W performance

-28.6%

FCF yield

9.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ARTV

EBS

Detailed metrics comparison

ARTV

Artiva Biotherapeutics Inc

EBS

Emergent BioSolutions Inc

Market Cap

ARTV$337M

EBS$364M

Enterprise Value

ARTV$36M

EBS$806M

Price

ARTV$6.94

EBS$7.06

P/E Ratio

ARTVN/A

EBSN/A

P/S Ratio

ARTV0.00x

EBS0.47x

EV/Sales

ARTV0.00x

EBS1.05x

EV/EBITDA

ARTV0.00x

EBS3.65x

P/B Ratio

ARTV0.96x

EBS0.95x

P/FCF Ratio

ARTVN/A

EBS10.26x

EV/FCF

ARTV-0.46x

EBS22.72x

PEG Ratio

ARTVN/A

EBSN/A

Forward P/E (NTM)

ARTVN/A

EBSN/A

Forward P/S (NTM)

ARTVN/A

EBSN/A

Revenue (TTM)

ARTV$0

EBS$770M

Revenue Growth (YoY)

ARTVN/A

EBS-9.6%

Forward Rev Growth

ARTV404.4%

EBS7.1%

Gross Margin (TTM)

ARTV0.0%

EBS55.8%

Operating Margin (TTM)

ARTV0.0%

EBS0.0%

EBITDA Margin (TTM)

ARTV0.0%

EBS28.7%

Net Margin (TTM)

ARTV0.0%

EBS-23.0%

FCF Margin (TTM)

ARTVN/A

EBS4.6%

Net Income (TTM)

ARTV$-42M

EBS$-177M

FCF (TTM)

ARTV$-77M

EBS$36M

EPS (TTM)

ARTV$0.00

EBS-$3.43

ROE (TTM)

ARTV-6022.0%

EBS-3591.0%

ROA (TTM)

ARTV-5238.0%

EBS-1356.0%

ROIC (TTM)

ARTV-6019.0%

EBS-1622.0%

Cash

ARTV$301M

EBS$140M

Debt

ARTV$0

EBS$582M

Net Cash/Debt

ARTV$301M

EBS$-442M

Current Ratio (TTM)

ARTV24.16x

EBS5.42x

Quick Ratio (TTM)

ARTV23.97x

EBS2.74x

Debt/Equity (TTM)

ARTV0.00x

EBS1.70x

Debt/Assets (TTM)

ARTV0.0%

EBS0.0%

Interest Coverage (TTM)

ARTVN/A

EBSN/A

Net Debt/EBITDA (TTM)

ARTV0.00x

EBS0.00x

Beta

ARTV5.80

EBS2.42

52W Performance

ARTV131.3%

EBS-28.6%

YTD Performance

ARTV64.1%

EBS-43.6%

% from 52W High

ARTV-52.2%

EBS-49.8%

% from 52W Low

ARTV156.1%

EBS61.9%

Asset Turnover (TTM)

ARTV0.00x

EBS0.59x

FCF Yield (TTM)

ARTV-22.8%

EBS9.7%

Earnings Yield (TTM)

ARTV-12.5%

EBS-48.5%

Dividend Yield (TTM)

ARTVN/A

EBSN/A

Rule of 40

ARTV0.0

EBS-4.9

EV/GP/RG

ARTVN/A

EBS0.27

Ticker research

View ARTV research View EBS research

Metric	ARTV Artiva Biotherapeutics Inc	EBS Emergent BioSolutions Inc
Market & Valuation
Market Cap	$337M	$364M
Enterprise Value	$36M	$806M
Price	$6.94	$7.06
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.47x
EV/Sales	0.00x	1.05x
EV/EBITDA	0.00x	3.65x
P/B Ratio	0.96x	0.95x
P/FCF Ratio	N/A	10.26x
EV/FCF	-0.46x	22.72x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$770M
Revenue Growth (YoY)	N/A	-9.6%
Forward Rev Growth	404.4%	7.1%
Profitability
Gross Margin (TTM)	0.0%	55.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	28.7%
Net Margin (TTM)	0.0%	-23.0%
FCF Margin (TTM)	N/A	4.6%
Net Income (TTM)	$-42M	$-177M
FCF (TTM)	$-77M	$36M
EPS (TTM)	$0.00	-$3.43
ROE (TTM)	-6022.0%	-3591.0%
ROA (TTM)	-5238.0%	-1356.0%
ROIC (TTM)	-6019.0%	-1622.0%
Financial Health
Cash	$301M	$140M
Debt	$0	$582M
Net Cash/Debt	$301M	$-442M
Current Ratio (TTM)	24.16x	5.42x
Quick Ratio (TTM)	23.97x	2.74x
Debt/Equity (TTM)	0.00x	1.70x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	5.80	2.42
52W Performance	131.3%	-28.6%
YTD Performance	64.1%	-43.6%
% from 52W High	-52.2%	-49.8%
% from 52W Low	156.1%	61.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.59x
FCF Yield (TTM)	-22.8%	9.7%
Earnings Yield (TTM)	-12.5%	-48.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-4.9
EV/GP/RG	N/A	0.27
Ticker research	View ARTV research	View EBS research

Valuation

P/S Ratio

ARTV

0.00x

EBS

0.47x

EV/FCF

ARTV

-0.46x

EBS

22.72x

Growth & revenue

Revenue Growth TTM

EBS

-9.6%

Forward Revenue Growth

ARTV

404.4%

EBS

7.1%

Profitability & performance

Gross Margin

EBS

55.8%

ARTV

0.0%

ROE

EBS

-3591.0%

ARTV

-6022.0%

FCF Yield %

EBS

9.7%

ARTV

-22.8%

52-Week Performance

ARTV

131.3%

EBS

-28.6%

Detailed metrics comparison

ARTV

Artiva Biotherapeutics Inc

EBS

Emergent BioSolutions Inc

Market Cap

ARTV$337M

EBS$364M

Enterprise Value

ARTV$36M

EBS$806M

Price

ARTV$6.94

EBS$7.06

P/E Ratio

ARTVN/A

EBSN/A

P/S Ratio

ARTV0.00x

EBS0.47x

EV/Sales

ARTV0.00x

EBS1.05x

EV/EBITDA

ARTV0.00x

EBS3.65x

P/B Ratio

ARTV0.96x

EBS0.95x

P/FCF Ratio

ARTVN/A

EBS10.26x

EV/FCF

ARTV-0.46x

EBS22.72x

PEG Ratio

ARTVN/A

EBSN/A

Forward P/E (NTM)

ARTVN/A

EBSN/A

Forward P/S (NTM)

ARTVN/A

EBSN/A

Revenue (TTM)

ARTV$0

EBS$770M

Revenue Growth (YoY)

ARTVN/A

EBS-9.6%

Forward Rev Growth

ARTV404.4%

EBS7.1%

Gross Margin (TTM)

ARTV0.0%

EBS55.8%

Operating Margin (TTM)

ARTV0.0%

EBS0.0%

EBITDA Margin (TTM)

ARTV0.0%

EBS28.7%

Net Margin (TTM)

ARTV0.0%

EBS-23.0%

FCF Margin (TTM)

ARTVN/A

EBS4.6%

Net Income (TTM)

ARTV$-42M

EBS$-177M

FCF (TTM)

ARTV$-77M

EBS$36M

EPS (TTM)

ARTV$0.00

EBS-$3.43

ROE (TTM)

ARTV-6022.0%

EBS-3591.0%

ROA (TTM)

ARTV-5238.0%

EBS-1356.0%

ROIC (TTM)

ARTV-6019.0%

EBS-1622.0%

Cash

ARTV$301M

EBS$140M

Debt

ARTV$0

EBS$582M

Net Cash/Debt

ARTV$301M

EBS$-442M

Current Ratio (TTM)

ARTV24.16x

EBS5.42x

Quick Ratio (TTM)

ARTV23.97x

EBS2.74x

Debt/Equity (TTM)

ARTV0.00x

EBS1.70x

Debt/Assets (TTM)

ARTV0.0%

EBS0.0%

Interest Coverage (TTM)

ARTVN/A

EBSN/A

Net Debt/EBITDA (TTM)

ARTV0.00x

EBS0.00x

Beta

ARTV5.80

EBS2.42

52W Performance

ARTV131.3%

EBS-28.6%

YTD Performance

ARTV64.1%

EBS-43.6%

% from 52W High

ARTV-52.2%

EBS-49.8%

% from 52W Low

ARTV156.1%

EBS61.9%

Asset Turnover (TTM)

ARTV0.00x

EBS0.59x

FCF Yield (TTM)

ARTV-22.8%

EBS9.7%

Earnings Yield (TTM)

ARTV-12.5%

EBS-48.5%

Dividend Yield (TTM)

ARTVN/A

EBSN/A

Rule of 40

ARTV0.0

EBS-4.9

EV/GP/RG

ARTVN/A

EBS0.27

Ticker research

View ARTV research View EBS research

Metric	ARTV Artiva Biotherapeutics Inc	EBS Emergent BioSolutions Inc
Market & Valuation
Market Cap	$337M	$364M
Enterprise Value	$36M	$806M
Price	$6.94	$7.06
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.47x
EV/Sales	0.00x	1.05x
EV/EBITDA	0.00x	3.65x
P/B Ratio	0.96x	0.95x
P/FCF Ratio	N/A	10.26x
EV/FCF	-0.46x	22.72x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$770M
Revenue Growth (YoY)	N/A	-9.6%
Forward Rev Growth	404.4%	7.1%
Profitability
Gross Margin (TTM)	0.0%	55.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	28.7%
Net Margin (TTM)	0.0%	-23.0%
FCF Margin (TTM)	N/A	4.6%
Net Income (TTM)	$-42M	$-177M
FCF (TTM)	$-77M	$36M
EPS (TTM)	$0.00	-$3.43
ROE (TTM)	-6022.0%	-3591.0%
ROA (TTM)	-5238.0%	-1356.0%
ROIC (TTM)	-6019.0%	-1622.0%
Financial Health
Cash	$301M	$140M
Debt	$0	$582M
Net Cash/Debt	$301M	$-442M
Current Ratio (TTM)	24.16x	5.42x
Quick Ratio (TTM)	23.97x	2.74x
Debt/Equity (TTM)	0.00x	1.70x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	5.80	2.42
52W Performance	131.3%	-28.6%
YTD Performance	64.1%	-43.6%
% from 52W High	-52.2%	-49.8%
% from 52W Low	156.1%	61.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.59x
FCF Yield (TTM)	-22.8%	9.7%
Earnings Yield (TTM)	-12.5%	-48.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-4.9
EV/GP/RG	N/A	0.27
Ticker research	View ARTV research	View EBS research